Nitya G. Ray - Net Worth and Insider Trading
Nitya G. Ray Net Worth
The estimated net worth of Nitya G. Ray is at least $609 dollars as of 2024-11-07. Nitya G. Ray is the Executive Vice President of Actinium Pharmaceuticals Inc and owns about 333 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $609. Details can be seen in Nitya G. Ray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nitya G. Ray has not made any transactions after 2017-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nitya G. Ray
Nitya G. Ray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nitya G. Ray owns 2 companies in total, including CytoDyn Inc (CYDY) , and Actinium Pharmaceuticals Inc (ATNM) .
Click here to see the complete history of Nitya G. Ray’s form 4 insider trades.
Insider Ownership Summary of Nitya G. Ray
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CYDY | CytoDyn Inc | 2018-12-22 | See Remarks |
ATNM | Actinium Pharmaceuticals Inc | 2017-08-02 | Executive Vice President |
Nitya G. Ray Latest Holdings Summary
Nitya G. Ray currently owns a total of 1 stock. Nitya G. Ray owns 333 shares of Actinium Pharmaceuticals Inc (ATNM) as of August 2, 2017, with a value of $609.
Latest Holdings of Nitya G. Ray
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATNM | Actinium Pharmaceuticals Inc | 2017-08-02 | 333 | 1.83 | 609 |
Holding Weightings of Nitya G. Ray
Nitya G. Ray Form 4 Trading Tracker
According to the SEC Form 4 filings, Nitya G. Ray has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 333 shares on August 2, 2017, which cost Nitya G. Ray around $7,500.
Insider Trading History of Nitya G. Ray
- 1
Nitya G. Ray Trading Performance
GuruFocus tracks the stock performance after each of Nitya G. Ray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nitya G. Ray is 0.62%. GuruFocus also compares Nitya G. Ray's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nitya G. Ray within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nitya G. Ray's insider trading performs compared to the benchmark.
Nitya G. Ray Ownership Network
Ownership Network List of Nitya G. Ray
Ownership Network Relation of Nitya G. Ray
Nitya G. Ray Owned Company Details
What does CytoDyn Inc do?
Who are the key executives at CytoDyn Inc?
Nitya G. Ray is the See Remarks of CytoDyn Inc. Other key executives at CytoDyn Inc include EVP of Legal Affairs Tyler Blok , President Arvin Cyrus Arman , and Chief Financial Officer Antonio Migliarese .
CytoDyn Inc (CYDY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytoDyn Inc Insider Transactions
Nitya G. Ray Mailing Address
Above is the net worth, insider trading, and ownership report for Nitya G. Ray. You might contact Nitya G. Ray via mailing address: 14 Baybury Court, East Hanover Nj 07936.